SOFIA (Bulgaria), December 1 (SeeNews) – Shares in Unipharm [BUL:59X] rose 4.82% to 4.35 levs ($2.36/2.22 euro) on the Sofia bourse on Thursday morning, as 1.65 million shares, representing a stake of 27.5% in the Bulgarian drug maker, changed hands.
Trading in Unipharm shares contributed 7.2 million levs to Bulgarian Stock Exchange's turnover of 7.5 million levs by 10:00 CET, bourse data showed. By comparison, total turnover from trading in shares on the BSE rose to 2.3 million levs on Wednesday, from 714,500 levs on Tuesday.
Last month, Unipharm announced a non-consolidated net profit of 540,000 levs for the January-September period, down from 1.23 million levs in the corresponding period of last year.
Unipharm is a medicinal products manufacturer that mainly invests in production and scientific implementation in the field of generic products. Unipharm manufactures its own products as well as products on contract manufacture for its main partner, Sofia-based Sopharma [BUL:3JR].
The company products are sold mainly on the Bulgarian market. Exports go to Russia, Ukraine, Georgia, Tunisia and others.
(1 euro = 1.95583 levs)